Home Latest News Purchase’s Cognition Therapeutics launches IPO

Purchase’s Cognition Therapeutics launches IPO

Cognition Therapeutics, a clinical-stage biopharmaceutical company headquartered in Purchase, announced Oct. 4 the launch of its initial public offering. 

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.